Endotext.org is the web-based source of information on endocrine disease written by physicians and directed to physicians around the world caring for patients with these problems. It is organized by Editor Leslie J De Groot, MD , Associate Editor Paolo Beck-Peccoz, MD, twelve Section Editors, and over 400 Authors. It is comprehensive, authoritative, constantly up-dated (last update 4 Oct 2014) , un-biased, and available without cost to physicians and trainees. All material may be freely downloaded for personal use. This site covers the broad area of Clinical Endocrinology, emphasizing clinical endocrine practice, including the most current information on the manifestations of endocrine disease, diagnosis and treatment. Endotext.org is the premier provider of well reviewed and organized clinical endocrine information on the Web.
Endotext.org is solely responsible for all content. The Department of Cell and Molecular Biology (CMB), an academic unit of the College of the Environment and Life Sciences at the University of Rhode Island, supports the publication of WWW.ENDOTEXT.ORG in association with the authors and editor, Dr. Leslie DeGroot, a member of CMB . Copyright © 2000-2013, MDText.com, Inc. All rights reserved.
Our site is made available through the fantastic generosity of the authors and editors who have provided their articles as a service to the profession. Vicente Cano is our Webmaster, and Henry De Groot, MD is our Internet Technology Consultant. We are supported in part by Unrestricted Educational Grants from pharmaceutical companies , and we are grateful to BAYER HEALTH CARE and IPSEN for helping make our educational website available to Endocrinologists world-wide. We also have several non-intrusive ads with hyperlinks to pharmaceutical company sites providing product information. For all questions on our site, advertising, and information, email email@example.com.
Please support our work via your contribution to MDText.com, Inc., P.O. Box P-94, South Dartmouth, MA 02748. to make a donation, click here